UK markets closed

NIKKEI 225
38,385.73
+29.67(+0.08%)
HANG SENG
19,073.71
-41.35(-0.22%)
CRUDE OIL
78.85
+0.83(+1.06%)
GOLD FUTURES
2,393.70
+33.80(+1.43%)
DOW
39,908.00
+349.89(+0.88%)
Bitcoin GBP
52,102.89
+3,541.87(+7.29%)

How to claim expenses at work without breaking the rules

Knowing more about tax rules can save you money

NanoViricides, Inc. (NNVC)

NYSE American - Nasdaq Real-time price. Currency in USD

Add to watchlist

1.8000

-0.4600

(-20.35%)

At close: 04:00PM EDT

1.7500

-0.05

(-2.78%)

After hours:

04:25PM EDT

Loading interactive chart…

ACCESSWIRE
NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun
NanoViricides, Inc. (NYSE American:NNVC) (the "Company") reports that clinical trials of its broad-spectrum antiviral drug NV-CoV-2 began on June 17, 2023 with two oral drug products: (i) NV-CoV-2 Oral Syrup, and (ii) NV-CoV-2 Oral Gummies.